학술논문

Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 1 2016, 27 1p. Supplement: 6
Subject
Language
English
ISSN
15698041